When dealing with exposure to radiations, what do we mean by strong or weak doses? Even among experts the question has led to much debate. For some, all exposure is dangerous: the smallest dose is already too strong. For others, the effects of radioactivity must not be overestimated. Levels of exposure in Western Europe as a consequence of the Chernobyl accident have all been correspondingly ‘weak’ - but this is not the perception among members of the public.
The United Nations scientific committee on the effects of atomic radiations (or UNSCEAR) has established a way of classifying exposure levels based on the thresholds above which deterministic effects occur, in other words effects which are felt by all individuals exposed above these thresholds. The UNSCEAR classification applies only to effective doses corresponding to acute global exposures, which means a dose received by the whole body during one short and intense irradiation. Deterministic effects can also appear with short doses administered to specific parts of the body: such as the testicles (transitory or permanent sterility), the ovaries (permanent sterility), the eyes (cataract) or the skin (erythema, necrosis).
One should distinguish between intense, short-lived exposures and the chronic and long-term exposures such as for instance the exposure to natural radioactivity. It is the deterministic effects caused by the first types that need to be considered in priority, since severe exposures to high levels of radiation can be life-threatening. This is why the UNSCEAR’s classification deals mainly with this type of exposure.
Effective doses below 200 millisieverts (mSv) are considered to be low or weak, and below 20 mSv they are said to be very low or very weak. Radiation absorbed in a medical context (excluding radiotherapy) as well as those occurring fronm natural sources fall into this category. Doses in this range are characterised by a lack of deterministic effects - i.e. short-term biological signs or post-radiation symptoms.
Such deterministic effects appear for acute effective doses classified as medium, strong and very strong by the UNSCEAR. Absorption of a dose between 0.5 and 2 sieverts (Sv) will result in a light reaction involving nausea, asthenia and vomiting between 3 and 6 hours after the exposure. Somewhere between 4 and 4.5 Sv lies the so-called DL50 level, which is the point at which exposure will be fatal in 50% of cases. Patients whose entire bodies have been exposed to doses of this magnitude will exhibit Acute Radiation Syndrome (ARS), a condition whose severity will depend on the dose absorbed, the exposure time, the type of radiation involved and the distribution of the radiation through the body. ARS is characterised by hematological symptoms (bone marrow damages), digestive symptoms (gastro-intestinal tract damages) and neurological symptoms in the central nervous system.